18 employees
DescriptionIFM Therapeutics is a pharmaceutical company focused on developing biological treatments for autoimmune diseases.
2017
$56M
from 5 investors over 5 rounds
IFM Therapeutics raised $56M on December 2, 2019
Investors: Omega Funds, Abingworth and Atlas Venture
IFM Therapeutics raised $27M on June 22, 2016
Investors: Atlas Venture and Abingworth